CLEARMIND MEDICINE ADVANCES CMND-100 TO DOSING PHASE AT HADASSAH MEDICAL CENTER IN ONGOING PHASE I/IIA CLINICAL TRIAL FOR ALCOHOL USE DISORDER

Reuters · 4d ago

Please log in to view news